9
Participants
Start Date
February 28, 2013
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2014
sildenafil
Subjects will be started on sildenafil at 20 mg PO TID at the baseline visit. Each individual will serve as his/her own control. Subjects will be evaluated at 3 months, with participation completed at that time.
University of Arizona Medical Center, Tucson
University of Arizona
OTHER